Abiopharma

I-Mab Announces Acceleration of Givastomig Investment and Leadership Appointments

Entera Bio Presents Positive Effects of EB613 on Both Trabecular and Cortical Bone in Postmenopausal Women with Osteoporosis at ASBMR 2025

Moleculin Doses First EU Patient in Phase 3 Pivotal MIRACLE Trial for Treatment of Acute Myeloid Leukemia

Evolus - Evolus Announces the Appointment of Tatjana Mitchell as Chief Financial Officer

Two New Publications from the Independent THERMAC Trial Featuring IceCures ProSense® in Breast Cancer Finds 95% of Patients Satisfied with Thermal Ablation; ProSense® Cryoablation Achieves Highest Complete Ablation Rate

Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton

CorMedix Announces Strategic Minority Investment in Talphera

Star Equity Holdings, Inc. RPO Subsidiary Rebrands to Hudson Talent Solutions

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

Lexicon Pharmaceuticals Announces Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes